Clinical Trial Update: Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, dosing, and preliminary activity of the combination therapy vorinostat and bortezomib in adults with multiple myeloma. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)
• Zolinza (vorinostat)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2011-04-06